
jueves, 17 de septiembre de 2009
La marca "contraataca"...
Although generic medications have long been touted for their cost-effectiveness, concerns have been raised about the effect of generic substitution in everyday practice, differences in bioequivalence standards for FDA approval, and recent manufacturing recalls. (Ver...)

Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario